Published in Science on May 31, 2013
PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov (2014) 4.81
Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science (2015) 2.80
The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell (2013) 2.79
Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell (2014) 2.68
Regulation of mTORC1 by amino acids. Trends Cell Biol (2014) 2.64
Sestrin2 is a leucine sensor for the mTORC1 pathway. Science (2015) 2.52
Nutrient-sensing mechanisms and pathways. Nature (2015) 2.46
Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell (2014) 2.15
Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science (2015) 2.14
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature (2015) 2.01
A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov (2014) 1.99
Where is mTOR and what is it doing there? J Cell Biol (2013) 1.91
Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell (2014) 1.87
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. Cell (2016) 1.85
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol (2017) 1.72
The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep (2014) 1.72
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. Nat Chem Biol (2016) 1.65
mTOR: a pharmacologic target for autophagy regulation. J Clin Invest (2015) 1.61
Nutrient sensing and signaling in the yeast Saccharomyces cerevisiae. FEMS Microbiol Rev (2014) 1.59
Regulation of mTORC1 by PI3K signaling. Trends Cell Biol (2015) 1.54
Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep (2014) 1.51
Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science (2015) 1.44
The neurology of mTOR. Neuron (2014) 1.43
Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J Cell Biol (2013) 1.43
Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell (2014) 1.40
Growing knowledge of the mTOR signaling network. Semin Cell Dev Biol (2014) 1.33
Nutrient-sensing mechanisms across evolution. Cell (2015) 1.30
Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9. Mol Cell Biol (2015) 1.27
Skp2-Mediated RagA Ubiquitination Elicits a Negative Feedback to Prevent Amino-Acid-Dependent mTORC1 Hyperactivation by Recruiting GATOR1. Mol Cell (2015) 1.19
Population genomics of the honey bee reveals strong signatures of positive selection on worker traits. Proc Natl Acad Sci U S A (2014) 1.17
Getting ready for building: signaling and autophagosome biogenesis. EMBO Rep (2014) 1.16
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging. Cell Metab (2016) 1.10
mTOR Signaling in Growth, Metabolism, and Disease. Cell (2017) 1.10
Translational control during endoplasmic reticulum stress beyond phosphorylation of the translation initiation factor eIF2α. J Biol Chem (2014) 1.07
SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation. Cell Cycle (2013) 1.07
mTOR signaling in tumorigenesis. Biochim Biophys Acta (2014) 1.06
Multiple amino acid sensing inputs to mTORC1. Cell Res (2015) 1.06
Definition and diagnostic criteria of sleep-related hypermotor epilepsy. Neurology (2016) 1.05
Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging. J Biol Chem (2013) 1.04
miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clin Cancer Res (2014) 1.02
Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Sci Rep (2015) 1.02
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Clin Cancer Res (2016) 1.01
Translational reprogramming in cellular stress response. Wiley Interdiscip Rev RNA (2013) 1.00
Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A. Nat Commun (2015) 0.99
Intersection of mTOR and STAT signaling in immunity. Trends Immunol (2014) 0.97
Regulation of autophagy by amino acids and MTOR-dependent signal transduction. Amino Acids (2014) 0.97
Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nat Commun (2015) 0.96
The Mon1-Ccz1 GEF activates the Rab7 GTPase Ypt7 via a longin-fold-Rab interface and association with PI3P-positive membranes. J Cell Sci (2014) 0.96
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol (2015) 0.96
Dysregulation of skeletal muscle protein metabolism by alcohol. Am J Physiol Endocrinol Metab (2015) 0.95
L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res (2015) 0.95
Toward rapamycin analog (rapalog)-based precision cancer therapy. Acta Pharmacol Sin (2015) 0.94
Molecular architecture and function of the SEA complex, a modulator of the TORC1 pathway. Mol Cell Proteomics (2014) 0.94
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci (2015) 0.93
The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol (2016) 0.93
Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot. Cell Metab (2016) 0.93
Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade. Cell Rep (2015) 0.92
RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Cell Signal (2013) 0.91
Atomic structure of the Y complex of the nuclear pore. Nat Struct Mol Biol (2015) 0.91
mTOR signaling in autophagy regulation in the kidney. Semin Nephrol (2013) 0.91
Sestrin regulation of TORC1: Is Sestrin a leucine sensor? Sci Signal (2016) 0.91
Genetic epilepsy syndromes without structural brain abnormalities: clinical features and experimental models. Neurotherapeutics (2014) 0.90
Advances in Autophagy Regulatory Mechanisms. Cells (2016) 0.90
Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis. Mol Biol Cell (2013) 0.89
The TORC1 inhibitors Nprl2 and Nprl3 mediate an adaptive response to amino-acid starvation in Drosophila. Cell Death Differ (2014) 0.89
Beyond indigestion: emerging roles for lysosome-based signaling in human disease. Curr Opin Cell Biol (2015) 0.89
Dynamic Visualization of mTORC1 Activity in Living Cells. Cell Rep (2015) 0.88
Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice. Aging Cell (2015) 0.88
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy. Front Physiol (2015) 0.88
The molecular basis for load-induced skeletal muscle hypertrophy. Calcif Tissue Int (2014) 0.88
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet (2015) 0.87
Mechanism of arginine sensing by CASTOR1 upstream of mTORC1. Nature (2016) 0.87
Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic. EMBO J (2016) 0.87
Localization of mTORC2 activity inside cells. J Cell Biol (2017) 0.86
Emerging role of mTOR in the response to cancer therapeutics. Trends Cancer (2016) 0.86
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. Elife (2016) 0.85
Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids. Int J Mol Sci (2014) 0.85
Dynamic relocation of the TORC1-Gtr1/2-Ego1/2/3 complex is regulated by Gtr1 and Gtr2. Mol Biol Cell (2015) 0.85
Epileptic spasms are a feature of DEPDC5 mTORopathy. Neurol Genet (2015) 0.85
Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics (2015) 0.85
Reciprocal conversion of Gtr1 and Gtr2 nucleotide-binding states by Npr2-Npr3 inactivates TORC1 and induces autophagy. Autophagy (2014) 0.84
Npr2 inhibits TORC1 to prevent inappropriate utilization of glutamine for biosynthesis of nitrogen-containing metabolites. Sci Signal (2014) 0.84
eIF4A inactivates TORC1 in response to amino acid starvation. EMBO J (2016) 0.84
Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. JAMA Neurol (2016) 0.84
NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition. Genes Dev (2015) 0.83
Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle. Am J Clin Nutr (2013) 0.83
Reassessment of the role of TSC, mTORC1 and microRNAs in amino acids-meditated translational control of TOP mRNAs. PLoS One (2014) 0.83
TORC1 regulators Iml1/GATOR1 and GATOR2 control meiotic entry and oocyte development in Drosophila. Proc Natl Acad Sci U S A (2014) 0.83
Cell signalling: nutrient sensing lost in cancer. Nature (2013) 0.83
Regulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2. Cell Rep (2015) 0.83
Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner. Autophagy (2015) 0.82
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism. Nutrients (2016) 0.81
The lysosome as a command-and-control center for cellular metabolism. J Cell Biol (2016) 0.81
Leucine induced dephosphorylation of Sestrin2 promotes mTORC1 activation. Cell Signal (2016) 0.81
Biochemical Basis of Sestrin Physiological Activities. Trends Biochem Sci (2016) 0.81
SEA you later alli-GATOR--a dynamic regulator of the TORC1 stress response pathway. J Cell Sci (2015) 0.81
GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling. Biochem J (2015) 0.81
Leucyl-tRNA Synthetase Activates Vps34 in Amino Acid-Sensing mTORC1 Signaling. Cell Rep (2016) 0.81
Using molecular biology to maximize concurrent training. Sports Med (2014) 0.80
Intestinal apical polarity mediates regulation of TORC1 by glucosylceramide in C. elegans. Genes Dev (2015) 0.80
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99
mTOR signaling in growth control and disease. Cell (2012) 29.21
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science (2008) 14.08
Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol (2009) 13.89
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell (2010) 12.24
mTOR and cancer: insights into a complex relationship. Nat Rev Cancer (2006) 11.86
Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol (2012) 10.87
Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol (2008) 8.92
mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science (2011) 7.55
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A (2001) 6.99
Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell (2012) 3.77
Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell (2012) 3.38
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res (2006) 3.31
Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics (2011) 3.28
Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. J Biol Chem (2000) 3.17
Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell (1990) 2.77
A conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae. Mol Cell Proteomics (2011) 2.34
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res (2012) 1.83
A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex. PLoS Genet (2009) 1.64
Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res (2002) 1.61
Mitochondria regulate autophagy by conserved signalling pathways. EMBO J (2011) 1.45
A practical approach to crosslinking. Mol Biol Rep (1993) 1.36
Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer (2005) 1.31
Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res (2004) 1.29
Selective regulation of autophagy by the Iml1-Npr2-Npr3 complex in the absence of nitrogen starvation. Mol Biol Cell (2011) 1.21
missing oocyte encodes a highly conserved nuclear protein required for the maintenance of the meiotic cycle and oocyte identity in Drosophila. Development (2004) 1.03
Membrane-coating lattice scaffolds in the nuclear pore and vesicle coats: commonalities, differences, challenges. Nucleus (2010) 0.94
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99
CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol (2006) 32.51
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
mTOR signaling in growth control and disease. Cell (2012) 29.21
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med (2005) 26.35
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol (2004) 16.83
The genetic landscape of a cell. Science (2010) 16.52
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13
CellProfiler: free, versatile software for automated biological image analysis. Biotechniques (2007) 14.71
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science (2008) 14.08
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem (2009) 12.73
High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68
A landscape of driver mutations in melanoma. Cell (2012) 12.61
High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods (2008) 12.56
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell (2010) 12.24
Cancer cell metabolism: Warburg and beyond. Cell (2008) 11.80
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Growing roles for the mTOR pathway. Curr Opin Cell Biol (2005) 11.66
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell (2006) 11.48
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol (2012) 10.87
Genetic screens in human cells using the CRISPR-Cas9 system. Science (2013) 10.75
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med (2008) 10.12
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet (2012) 9.93
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell (2007) 9.68
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res (2008) 9.29
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res (2004) 8.86
mTOR signaling at a glance. J Cell Sci (2009) 8.66
Integrative analysis of the melanoma transcriptome. Genome Res (2010) 8.46
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 8.37
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A (2008) 8.08
Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 8.07
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03
LKB1 modulates lung cancer differentiation and metastasis. Nature (2007) 7.80
Melanoma genome sequencing reveals frequent PREX2 mutations. Nature (2012) 7.77
Sequence analysis of mutations and translocations across breast cancer subtypes. Nature (2012) 7.76
Pan-cancer patterns of somatic copy number alteration. Nat Genet (2013) 7.73
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res (2006) 7.61
Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell (2007) 7.60
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 7.59
mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science (2011) 7.55
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A (2008) 7.45
The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol (2002) 7.44
Punctuated evolution of prostate cancer genomes. Cell (2013) 7.23
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med (2006) 6.96
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res (2005) 6.93
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 6.89
Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature (2008) 6.80
The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science (2011) 6.75
Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science (2012) 6.69
A unifying model for mTORC1-mediated regulation of mRNA translation. Nature (2012) 6.44
Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet (2009) 6.35
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet (2010) 6.10
Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell (2004) 6.08
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med (2005) 6.04
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell (2009) 5.97
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods (2006) 5.96
Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res (2008) 5.95
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell (2007) 5.95
Comment on "The consensus coding sequences of human breast and colorectal cancers". Science (2007) 5.88
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71